Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics' Ivonescimab shows promising survival benefits in Phase III trials, with potential FDA BLA filing and anticipation of an AstraZeneca partnership overshadowing trial design concerns.

### About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc. Common Stock (SMMT) is a publicly traded stock in the healthcare sector.  
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Summit Therapeutics Inc. Common Stock (SMMT) sentiment near a 52-week low at XX.
- Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/close.tsv)  
The recent 7-day price increase for SMMT is attributed to positive trial data and insider buying, which are currently overshadowing concerns about trial design.  

24-Hour: XXXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXX on 2025-04-24  
1-Year Low: $XXXXX on 2025-11-21  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/alt_rank.tsv)  
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #843 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XX  
X Month: XXX -XXX  
X Months: XXX +778  
X Year: XXX +179  
1-Year High: XXXXX on 2025-08-11  
1-Year Low: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX +1  
X Months: XX +14  
X Year: XX +3  
1-Year High: XX on 2025-04-22  
1-Year Low: X on 2025-03-18  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-04-25  
1-Year Low: XXX on 2025-12-06  

Engagements by network (24h):
News: XX
Reddit: XX
X: XXXXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX +3.60%  
X Month: XXX -XX%  
X Months: XXXXX +6.70%  
X Year: XXXXXX +30%  
1-Year High: XXX on 2025-07-18  
1-Year Low: XX on 2025-12-02  

Mentions by network (24h):
News: X
Reddit: XX
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XXX +3.50%  
X Month: XXX -XX%  
X Months: XXXXX +57%  
X Year: XXXXX +71%  
1-Year High: XXX on 2025-07-18  
1-Year Low: XX on 2025-12-06  

The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | XX    | XXX         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | X    | XXX       | X     | XXX         |
| [@SteveIHayes](/creator/twitter/SteveIHayes)         | X    | XX        | X     | XXX         |
| [@DenverMichaeI](/creator/twitter/DenverMichaeI)     | X    | XX        | X     | XXX         |
| [@CarolAlThompson](/creator/twitter/CarolAlThompson) | X    | XXX       | X     | XXX         |
| [@mariostario2019](/creator/twitter/mariostario2019) | X    | XX        | X     | XXX         |
| [@JulieSAGreen](/creator/twitter/JulieSAGreen)       | X    | XXX       | X     | XXX         |
| [@FrenzyCapital](/creator/twitter/FrenzyCapital)     | X    | XXXXX     | X     | XXX         |
| [@KathleenHGraham](/creator/twitter/KathleenHGraham) | X    | XXX       | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)             | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$smmt/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-10-07  
1-Year Low: XX% on 2025-03-23  

Most Supportive Themes:
- Insider Buying: (30%) Executives are actively purchasing shares, indicating strong confidence in the company's future prospects.
- Phase III Development Expansion: (25%) The expansion of the global Phase III development program for Ivonescimab suggests positive progress and potential for future drug approvals.
- Potential AstraZeneca Partnership: (20%) Anticipation of a partnership with AstraZeneca is driving bullish sentiment and investor interest.
  
Most Critical Themes:
- Trial Design Concerns: (15%) There are underlying concerns regarding the trial design and potential FDA approval, which could pose risks.
- Market Skepticism: (10%) Despite positive news, there is market skepticism about the company's turnaround narrative and execution risks.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.0074%  
X Month: XXXXX% +0.013%  
X Months: XXXXX% -XXXXXX%  
X Year: XXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-04-25  
1-Year Low: XXXXXX% on 2025-10-07  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXX% on 2025-04-24  
1-Year Low: XXXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$0.70%  
X Month: $XXXXXXXXXXXXXX -$5.80%  
X Months: $XXXXXXXXXXXXXX -$15%  
X Year: $XXXXXXXXXXXXXX -$7.30%  
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24  
1-Year Low: $XXXXXXXXXXXXXX on 2025-11-21  

### Top Summit Therapeutics Inc. Common Stock News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Summit Therapeutics Inc. (SMMT): Among the Stocks That Will Go to the Moon According to Analysts"  
[News Link](https://finance.yahoo.com/news/summit-therapeutics-inc-smmt-among-181432743.html) [@YahooFinance](/creator/x/YahooFinance) 2025-04-09T16:16Z 228.6M followers, 112.6K engagements



### Top Summit Therapeutics Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"This is overdue See you over $X $GSUN $MTC $CMND $SMMT $EVER $ZETA $JMIA $PTON $STRL $TRUP $DAVE $ESPR $ALXO $SYM $FN $CRGY $FMC $SGRY $IART $WEAV $CROX $GFS $ADUS $ARVN $GOGO $HIMS $VCEL $IP $BRFS $DK $SKK $DBGI $XCUR $BENF $CLNN $MOGU $XOS $ESTC $SIGI $PRTH $DRCT $QUBT $ASST"  
[X Link](https://x.com/mariostario2019/status/1998506133829329037) [@mariostario2019](/creator/x/mariostario2019) 2025-12-09T21:32Z XX followers, XXX engagements


"Dont hesitate to load $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"  
[X Link](https://x.com/BuyTheUgly/status/1998485633111556595) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:11Z XX followers, XXX engagements


"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"  
[X Link](https://x.com/BuyTheUgly/status/1998485125680738411) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements


"Stock market watchlist #1 $RUBI #2 $ASST#3 $FGL #4 $RELI #5 $VNRX #6 $IVP #7 $CHR #8 $BNED#9 $CMND $SMMT $CPRX $CRMD $HUMA $MREO $TCRX $SCPL $VTGN $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"  
[X Link](https://x.com/ParadiseTraderr/status/1998484362669768941) [@ParadiseTraderr](/creator/x/ParadiseTraderr) 2025-12-09T20:06Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics' Ivonescimab shows promising survival benefits in Phase III trials, with potential FDA BLA filing and anticipation of an AstraZeneca partnership overshadowing trial design concerns.

About Summit Therapeutics Inc. Common Stock

Summit Therapeutics Inc. Common Stock (SMMT) is a publicly traded stock in the healthcare sector.
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the Stocks category.

Insights

  • Summit Therapeutics Inc. Common Stock (SMMT) sentiment near a 52-week low at XX.
  • Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXXX% from the previous week.
  • Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXX% from the previous week.
  • Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXX% from the previous week.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The recent 7-day price increase for SMMT is attributed to positive trial data and insider buying, which are currently overshadowing concerns about trial design.

24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2025-04-24
1-Year Low: $XXXXX on 2025-11-21

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #843 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XX
X Month: XXX -XXX
X Months: XXX +778
X Year: XXX +179
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-02-09

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX +1
X Months: XX +14
X Year: XX +3
1-Year High: XX on 2025-04-22
1-Year Low: X on 2025-03-18

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-12-06

Engagements by network (24h): News: XX Reddit: XX X: XXXXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +3.60%
X Month: XXX -XX%
X Months: XXXXX +6.70%
X Year: XXXXXX +30%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-12-02

Mentions by network (24h): News: X Reddit: XX X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XXX
X Week: XXX +3.50%
X Month: XXX -XX%
X Months: XXXXX +57%
X Year: XXXXX +71%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-12-06

The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@BuyTheUgly X XX XX XXX
@ParadiseTraderr X XXX X XXX
@SteveIHayes X XX X XXX
@DenverMichaeI X XX X XXX
@CarolAlThompson X XXX X XXX
@mariostario2019 X XX X XXX
@JulieSAGreen X XXX X XXX
@FrenzyCapital X XXXXX X XXX
@KathleenHGraham X XXX X XXX
@seedytx19 XX XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-10-07
1-Year Low: XX% on 2025-03-23

Most Supportive Themes:

  • Insider Buying: (30%) Executives are actively purchasing shares, indicating strong confidence in the company's future prospects.
  • Phase III Development Expansion: (25%) The expansion of the global Phase III development program for Ivonescimab suggests positive progress and potential for future drug approvals.
  • Potential AstraZeneca Partnership: (20%) Anticipation of a partnership with AstraZeneca is driving bullish sentiment and investor interest.

Most Critical Themes:

  • Trial Design Concerns: (15%) There are underlying concerns regarding the trial design and potential FDA approval, which could pose risks.
  • Market Skepticism: (10%) Despite positive news, there is market skepticism about the company's turnaround narrative and execution risks.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.0074%
X Month: XXXXX% +0.013%
X Months: XXXXX% -XXXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-04-25
1-Year Low: XXXXXX% on 2025-10-07

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-04-24
1-Year Low: XXXXX% on 2025-12-10

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$0.70%
X Month: $XXXXXXXXXXXXXX -$5.80%
X Months: $XXXXXXXXXXXXXX -$15%
X Year: $XXXXXXXXXXXXXX -$7.30%
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24
1-Year Low: $XXXXXXXXXXXXXX on 2025-11-21

Top Summit Therapeutics Inc. Common Stock News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"Summit Therapeutics Inc. (SMMT): Among the Stocks That Will Go to the Moon According to Analysts"
News Link @YahooFinance 2025-04-09T16:16Z 228.6M followers, 112.6K engagements

Top Summit Therapeutics Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"This is overdue See you over $X $GSUN $MTC $CMND $SMMT $EVER $ZETA $JMIA $PTON $STRL $TRUP $DAVE $ESPR $ALXO $SYM $FN $CRGY $FMC $SGRY $IART $WEAV $CROX $GFS $ADUS $ARVN $GOGO $HIMS $VCEL $IP $BRFS $DK $SKK $DBGI $XCUR $BENF $CLNN $MOGU $XOS $ESTC $SIGI $PRTH $DRCT $QUBT $ASST"
X Link @mariostario2019 2025-12-09T21:32Z XX followers, XXX engagements

"Dont hesitate to load $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"
X Link @BuyTheUgly 2025-12-09T20:11Z XX followers, XXX engagements

"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"
X Link @BuyTheUgly 2025-12-09T20:09Z XX followers, XXX engagements

"Stock market watchlist #1 $RUBI #2 $ASST#3 $FGL #4 $RELI #5 $VNRX #6 $IVP #7 $CHR #8 $BNED#9 $CMND $SMMT $CPRX $CRMD $HUMA $MREO $TCRX $SCPL $VTGN $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"
X Link @ParadiseTraderr 2025-12-09T20:06Z XXX followers, XXX engagements

Summit Therapeutics Inc. Common Stock (SMMT)
/topic/$smmt